Pulmonary and extrapulmonary morbidity and mortality in COPD

A. Valipour (Vienna, Austria)**

Source: School Course 2012 - Clinical challenges in COPD: a bedside teaching course
Number: 1
Disease area: Airway diseases

PDF journal article, handout or slidesSlide presentation

Rating: 4.5
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
A. Valipour (Vienna, Austria)**. Pulmonary and extrapulmonary morbidity and mortality in COPD. School Course 2012 - Clinical challenges in COPD: a bedside teaching course

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Cardiovascular mortality and morbidity in pulmonary embolism
Source: Eur Respir Monogr 2020; 88: 184-197
Year: 2020


Predictors of mortality in chronic pulmonary aspergillosis
Source: Eur Respir J , 49 (2) 1601062; DOI: 10.1183/13993003.01062-2016
Year: 2017




Predicting risk of mortality of chronic pulmonary aspergillosis
Source: Virtual Congress 2020 – Aspergillosis and chronic lung infections
Year: 2020


Analysis of mortality incidence in patients with pulmonary tuberculosis
Source: Eur Respir J 2002; 20: Suppl. 38, 555s
Year: 2002

The impact of dynamic lung hyperinflation on morbidity and mortality in patients with chronic obstructive pulmonary disease
Source: Annual Congress 2009 - Risk factors for COPD
Year: 2009


COPD is associated with increased mortality in patients with community-acquired pneumonia
Source: Eur Respir J 2006; 28: 346-351
Year: 2006



Pulmonary thromboembolism as the cause of death in patients with COPD
Source: Eur Respir J 2001; 18: Suppl. 33, 483s
Year: 2001

Severity and outcomes of hospitalised community-acquired pneumonia in COPD patients
Source: Eur Respir J 2012; 39: 855-861
Year: 2012



Surgical morbidity and mortality in lung cancer patients with idiopathic pulmonary fibrosis
Source: Eur Respir J 2006; 28: Suppl. 50, 782s
Year: 2006

Impact of pulmonary tuberculosis on COPD outcomes
Source: Virtual Congress 2021 – Advances in treatment and management of tuberculosis and nontuberculous mycobacterial disease
Year: 2021



Differential diagnosis and impact of cardiovascular comorbidities and pulmonary embolism during COPD exacerbations
Source: Eur Respir Monogr 2017; 77: 114-128
Year: 2017


Risk factors of intrahospital mortality for pulmonary tuberculosis
Source: Annual Congress 2007 - Clinical epidemiology of tuberculosis
Year: 2007


Respiratory comorbidities and risk of mortality in hospitalized patients with idiopathic pulmonary fibrosis.
Source: International Congress 2017 – ILDs: clinical aspects
Year: 2017

Morbidity and mortality in patients with chronic obstructive pulmonary disease and cachexia
Source: Annual Congress 2009 - Prognosis and comorbidities in COPD
Year: 2009


Pulmonary embolism in patients in hospital with a COPD exacerbation
Source: ISSN=ISSN 1810-6838, ISBN=, page=283
Year: 2007

Pulmonary sequelae of pneumonia
Source: Annual Congress 2004 - PG18 - Childhood pneumonia after the turn of the new millennium
Year: 2004

Predictors of mortality in COPD
Source: Annual Congress 2008 - COPD - clinical and epidemiological aspects
Year: 2008

Predictors of mortality in COPD
Source: Annual Congress 2009 - Prognosis and comorbidities in COPD
Year: 2009


Pulmonary embolism in patients with COPD
Source: Virtual Congress 2021 – Highlights from the JAMA Network on idiopathic pulmonary fibrosis, chronic obstructive pulmonary disease and lung cancer screening
Year: 2021